[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.191.72. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
November 8, 1952

CAUTION NECESSARY IN THE TREATMENT OF RENAL TUBERCULOSIS WITH ISONIAZID

Author Affiliations

New York
From the Squier Urological Clinic, Columbia University College of Physicians and Surgeons, and the Research Unit for Genitourinary Tuberculosis, Veterans Administration Hospital, Bronx, New York 68.

JAMA. 1952;150(10):981-983. doi:10.1001/jama.1952.03680100023007
Abstract

Early in 1952 the newspapers reported a new "wonder drug" for tuberculosis. The name of this drug is isoniazid (isonicotinic acid hydrazide). It is at least 600 times more powerful than p-aminosalicylic acid and appears more powerful than streptomycin in killing tubercle bacilli, at least in the test tube. Whether it will be as effective in vivo remains to be seen. Isoniazid does have a place in the treatment of renal tuberculosis. Like streptomycin, it brings about a gradual improvement in the cystoscopic appearance of the lesions of tuberculous cystitis and makes the urine culture sterile for tubercle bacilli in most patients. It is an excellent drug for the treatment of streptomycin-resistant patients. It is not toxic for the nephrons. One patient, who is living on only two renal pyramids, has shown a fall of the blood urea nitrogen level from 100 mg. per 100 cc. down to 25

First Page Preview View Large
First page PDF preview
First page PDF preview
×